Respiratory Syncytial Virus

Looking like a nice drop below prospective value to ~ $3.5 before the end of September.

 

I was expecting the bottom to fall out at the end, however it looks like a substantial buyer has stepped in just above $4.1. I'd be reaccumulating my shorts here, and be on guard for a shakeout to wholesale value as a buying opportunity.

 

Recent RS in this stock.

 

mistaken embed

 

Alphatrends mentioned it. IBB @ 6:40 mark, NVAX 7:18-32.
He is long.

 

RSV is bread and butter gives me phenomenal price target.

But Ebola? OMG http://finance.yahoo.com/news/novavax-announces-ebola-vaccine-development-113000538.html

 

NVAX just got fast track designation for H7N9 vaccine candidate.

 

http://bcove.me/yiyn6rjr